You are here: Home / Archives for shawn xiang

shawn xiang

Siqi Wang awarded SPIE Optics + Photonics Career Summit Officer Travel Grant

by

TRUE lab graduate student researcher Siqi Wang has been awarded a 2020 SPIE Optics + Photonics Career Summit Officer Travel Grant from SPIE, the international society for optics and photonics, for his potential contributions to the field.

Siqi’s research involves developing innovative X-ray induced acoustic computed tomography (XACT) for biomedical applications.

Siqi has been invited to participate the upcoming SPIE Career Summit held during SPIE Optics + Photonics (23-27 August in San Diego, California).

Dr. Xiang receives Presidential Professorship

by

Liangzhong “Shawn” Xiang has received Lloyd G. and Joyce Austin Presidential Professorship.

Xiang emphasizes teaching students cutting-edge research and advanced technologies through active research programs that effectively complement classroom studies and enhance the undergraduate and graduate curricula.

He received the Nancy L. Mergler Faculty Mentor Award for Undergraduate Research at OU in 2017. In addition to the support of undergraduate students through his individual mentoring, he also mentors undergraduate student researchers in his lab through the University of Oklahoma Undergraduate Research Opportunities Program, First Year Research Experience, and the Honors Research Assistant Program.

The Presidential Professorships were established to recognize those faculty members who excel in all their professional activities and who relate those activities to the student they teach and mentor. The number of Professorships awarded annually is based on current availability of funds.

Dr. Xiang receives American Cancer Society Research Scholar Grant

by

    Liangzhong (Shawn) Xiang, Ph.D., an assistant professor at University of Oklahoma, has received a four-year, $792,000 Research Scholar Grant from the American Cancer Society.

    The American Cancer Society awards Research Scholar Grants for promising research projects that may lead to the elimination of cancer as a major health problem. Recipients must be in the first six years of an independent research career or faculty appointment.

    Dr. Xiang, who has been at OU since 2015, will use the grant to study how X-ray induced acoustic computed tomography (XACT) will applied for in vivo dosimetry during prostate radiotherapy.

    “I’m very grateful to the American Cancer Society for supporting this research,” says Dr. Xiang. “ We expect XACT imaging can used to 1) localize the radiation beam and 2) estimate the in-line verify radiation dose in real time during prostate radiotherapy. ”

    TRUE lab receives OU’s first National Institutes of Health MERIT (R37) Award

    by

    NORMAN, OKLA. – The quest to conquer cancer is motivating a team of researchers at the University of Oklahoma to develop a 3D scanner capable of guiding the radiation treatment, dispensing just the right amount of radiation to just the precise location, making real-time adjustments as treatment is delivered.

    The initial five year $2.1million grant is the first NIH Method to Extend Research in Time (MERIT R37) Award, issued to a researcher at the University of Oklahoma’s Norman campus. An extension of funding for two additional two years will be issued based on NCI review of the accomplishments during the initial funding segment. Liangzhong Xiang, assistant professor in the School of Electrical and Computer Engineering is leading the team that includes OU Medicine physicists Yong Chen and Salahuddin Ahmad, together with radiation oncologist Dr. Terence Herman and commercial product expert from PhotoSound Technologies, Inc., Dr. Vassili Ivanov.

    The scanner will rely on X-ray-induced Acoustic Computed Tomography (XACT), a process that measures acoustic signals generated by X-rays as they are absorbed by human tissue. By detecting the acoustic waves, real-time visualization of the X-ray beam inside the patient quantifies the precise radiation dose deliveried to the tumor.

    The impact of the proposed XACT imaging is to not only provide a novel imaging tool to accurately verify in-patient radiation doses, but also to provide real-time feedback for adaptive therapy during treatment. The technological advancements in XACT imaging will decrease radiation treatment toxicity and improve clinical outcomes for cancer patients.

    The R37 is a Method to Extend Research in Time (MERIT) and provides longer term grant support to Early Stage Investigators. The objective of the NCI’s ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to seven years of support in two segments, with the first being an initial five-year award and the second being based on an opportunity for an extension of up to two additional years, based on an expedited NCI review of the accomplishments during the initial funding segment. Unlike most NIH grant awards, the MERIT award can not be applied for by the investigator.